Earlens Corporation

Earlens Corporation

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://www.earlens.com

Last Round

Series E

Apr 4, 2024

Total Funding Raised

$273.25M

Company Overview

EarLens is a healthcare technology company that develops a contact hearing device aimed at transforming sound performance standards by directly activating the natural hearing system with low-frequency radio and a small lens on the eardrums, ensuring clear hearing in challenging environments with minimal feedback.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Computing Hardware

Business Model

B2B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

contact hearing solutiondirect drive hearing aidhearing contact lenshearing aidsensorineural hearing lossnon-surgical hearing solutionextended frequency rangefeedback-free hearing aidmedical devicephysician-dispensedcustom-fit hearing aidmedtechB2B2C distribution

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Earlens Corporation Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Earlens Corporation Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series EApr 4, 2024
Convertible DebtApr 14, 2022
Series DOct 22, 2018
DebtJun 5, 2017
Series CMay 24, 2017
Series B
Apr 14, 2014

Key People

Founding team and executive leadership

Drew Dundas

Chief Technology Officer

Executive Team

Earlens Corporation Investors

Notable investors and investment history

InvestorRounds
KCK MedTechSeries D
Vertex Ventures HCSeries D, Series C
Relativity Healthcare PartnersSeries D
New Enterprise Associates (NEA)Series D, Series C, Series B
Lightstone VenturesSeries D, Series C, Series B
Andrew W. Mellon FoundationSeries D
Baltisches Haus LimitedSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Plans to open four new clinic locations across San Diego County.

  • May 15, 2025

    Collaborating to build an automated referral program for customer acquisition.

Earlens Corporation Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Earlens Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Earlens Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersMenlo Park, California
Employee Range109
Year Founded2005
Last FundingApr 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.